单孔电视辅助胸腔镜手术用于肺癌术后加速康复:初步研究。

Enhanced recovery after surgery using uniportal video-assisted thoracic surgery for lung cancer: A preliminary study.

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.

出版信息

Thorac Cancer. 2018 Jan;9(1):83-87. doi: 10.1111/1759-7714.12541. Epub 2017 Oct 31.

Abstract

BACKGROUND

This study investigated the clinical efficiency of enhanced recovery after surgery (ERAS) using uniportal video-assisted thoracoscopic surgery for lung cancer.

METHODS

The clinical data of 83 patients with early-stage non-small cell lung cancer (NSCLC) at the First Affiliated Hospital of Soochow University from January 2016 to February 2017 were retrospectively analyzed. ERAS was applied to 38 patients (ERAS group), while 45 patients received conventional surgical treatment (control group). The operative duration, number of lymph nodes retrieved, blood loss, visual analogue scale (VAS), postoperative duration of chest tube placement, length of hospital stay, and postoperative complications were compared between the groups.

RESULTS

Surgeries were conducted successfully in all patients, and no mortality occurred during the perioperative period. The ERAS group had better VAS on the third postoperative day, shorter chest tube duration, and shorter length of hospital stay (P < 0.05). No differences between the groups in terms of operative duration, number of lymph nodes retrieved, blood loss, VAS on the first postoperative day, or complication rate were found (P > 0.05).

CONCLUSIONS

ERAS using uniportal video-assisted thoracoscopic surgery for NSCLC patients is safe and practicable, and could also reduce the length of hospital stay.

摘要

背景

本研究探讨了单孔电视辅助胸腔镜手术(uniportal video-assisted thoracoscopic surgery,VATS)联合加速康复外科(enhanced recovery after surgery,ERAS)治疗肺癌的临床疗效。

方法

回顾性分析 2016 年 1 月至 2017 年 2 月苏州大学第一附属医院收治的 83 例早期非小细胞肺癌(non-small cell lung cancer,NSCLC)患者的临床资料。ERAS 组(n=38)采用 ERAS 治疗,常规治疗组(n=45)采用常规治疗。比较两组患者的手术时间、淋巴结清扫数量、术中出血量、视觉模拟评分(visual analogue scale,VAS)、术后胸腔引流管留置时间、住院时间及术后并发症。

结果

所有患者均顺利完成手术,围手术期无死亡病例。ERAS 组患者术后第 3 天的 VAS 评分更低,胸腔引流管留置时间和住院时间更短(P<0.05)。两组患者的手术时间、淋巴结清扫数量、术中出血量、术后第 1 天 VAS 评分及并发症发生率差异均无统计学意义(P>0.05)。

结论

单孔 VATS 联合 ERAS 治疗 NSCLC 安全可行,可缩短患者的住院时间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索